Covid-19 Vaccines vs. The Bottom Line | Crash Course
January 17, 2023
152
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Podcasts Episodes Around January 17, 2023
See what was published immediately before and after this episode.
40:34Now PlayingCovid-19 Vaccines vs. The Bottom Line | Crash Course
YouTube Description
as posted by the channelTim O’Brien is not a scientist. But he is a user of Covid-19 vaccines. He thinks they’re miracles, and the single biggest reason the pandemic wasn’t more devastating. But if that perspective makes you erupt, please relax: Crash Course is focusing today on the companies that make the vaccines, not the science. And Tim has a question: Have those amazing innovators – those life-savers – played fairly when it comes to sharing the financial spoils of their miracle drugs? And they were miracles. Just about nine months after the US went into lockdown in March 2020, the first vaccine jabs were available. There are a handful of marquee companies that won that race, Pfizer, BioNTech, Johnson & Johnson, and AstraZeneca among them. But today, for purposes of a lively discussion about innovation and avarice, Crash Course will focus on Moderna, which is a useful proxy for examining how a groundbreaking vaccine was unearthed – and who got control of its uses.
To do that, Crash Course has invited Dr. Monica Gandhi, a leading virologist and epidemiologist who also teaches at the University of California San Francisco, to join our podcast.
See omnystudio.com/listener () for privacy information.
Hosted by Bloomberg Opinion senior executive editor Tim O'Brien, Crash Course will bring listeners directly into the arenas where epic business and social upheavals occur. Every week, Crash Course will explore the lessons to be learned when creativity and ambition collide with competition and power -- on Wall Street and Main Street, and in Hollywood and Washington.
Listen to more Crash Course
Subscribe to Bloomberg Podcasts
#Bloomberg #Podcast
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Markets & Finance
Bloomberg Politics
Bloomberg Technology
For coverage on news, markets and more
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.